La cooperazione tra gli stakeholder per la sostenibilità del nuovo paradigma farmaceutico in Italia.
Saved in:
| Transliterated Title: | La cooperazione tra gli stakeholder per la sostenibilità del nuovo paradigma farmaceutico in Italia. |
|---|---|
| Authors: | Drago V; Managing Director, S.C.F. Studio di Consulenza Farmacologica, Catania - Italy., Di Brino E; Altems Advisory, spin-off dell'Università Cattolica del Sacro Cuore, Roma - Italy., Laurita R; Department of Economics and Business Management, Università Cattolica del Sacro Cuore, Milano - Italy., Rumi F; Altems Advisory, spin-off dell'Università Cattolica del Sacro Cuore, Roma - Italy., Basile M; Altems Advisory, spin-off dell'Università Cattolica del Sacro Cuore, Roma - Italy., Pierini A; Access Partnership Lead Integrated Access Management, Roche, Monza - Italy., Ponzianelli A; Director of Market Access & Public Affairs, Moderna, Roma - Italy., Patarnello F; Vice-President Market Access & Government Affairs, AstraZeneca Italia, Milano - Italy., Ianna P; Head of Value Access Oncology, Daiichi Sankyo Italia S.p.A., Milano - Italy., Drago F; Clinical Pharmacology Unit-Regional Pharmacovigilance Centre, University Hospital of Catania, Catania - Italy.; Department of Biomedical and Biotechnological Sciences, University of Catania, Catania - Italy.; Centre for Research and Consultancy in HTA and Drug Regulatory Affairs (CERD), University of Catania, Catania - Italy. |
| Source: | Global & regional health technology assessment [Glob Reg Health Technol Assess] 2026 Feb 09; Vol. 13, pp. 24-32. Date of Electronic Publication: 2026 Feb 09 (Print Publication: 2026). |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: AboutScience Country of Publication: Italy NLM ID: 9918417986506676 Publication Model: eCollection Cited Medium: Internet ISSN: 2283-5733 (Electronic) Linking ISSN: 22842403 NLM ISO Abbreviation: Glob Reg Health Technol Assess Subsets: PubMed not MEDLINE |
| Database: | MEDLINE Ultimate |
| FullText | Text: Availability: 0 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 41669617 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: – Name: TitleTranslated Label: Transliterated Title Group: TiAlt Data: La cooperazione tra gli stakeholder per la sostenibilità del nuovo paradigma farmaceutico in Italia. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Drago+V%22">Drago V</searchLink>; Managing Director, S.C.F. Studio di Consulenza Farmacologica, Catania - Italy.<br /><searchLink fieldCode="AU" term="%22Di+Brino+E%22">Di Brino E</searchLink>; Altems Advisory, spin-off dell'Università Cattolica del Sacro Cuore, Roma - Italy.<br /><searchLink fieldCode="AU" term="%22Laurita+R%22">Laurita R</searchLink>; Department of Economics and Business Management, Università Cattolica del Sacro Cuore, Milano - Italy.<br /><searchLink fieldCode="AU" term="%22Rumi+F%22">Rumi F</searchLink>; Altems Advisory, spin-off dell'Università Cattolica del Sacro Cuore, Roma - Italy.<br /><searchLink fieldCode="AU" term="%22Basile+M%22">Basile M</searchLink>; Altems Advisory, spin-off dell'Università Cattolica del Sacro Cuore, Roma - Italy.<br /><searchLink fieldCode="AU" term="%22Pierini+A%22">Pierini A</searchLink>; Access Partnership Lead Integrated Access Management, Roche, Monza - Italy.<br /><searchLink fieldCode="AU" term="%22Ponzianelli+A%22">Ponzianelli A</searchLink>; Director of Market Access & Public Affairs, Moderna, Roma - Italy.<br /><searchLink fieldCode="AU" term="%22Patarnello+F%22">Patarnello F</searchLink>; Vice-President Market Access & Government Affairs, AstraZeneca Italia, Milano - Italy.<br /><searchLink fieldCode="AU" term="%22Ianna+P%22">Ianna P</searchLink>; Head of Value Access Oncology, Daiichi Sankyo Italia S.p.A., Milano - Italy.<br /><searchLink fieldCode="AU" term="%22Drago+F%22">Drago F</searchLink>; Clinical Pharmacology Unit-Regional Pharmacovigilance Centre, University Hospital of Catania, Catania - Italy.; Department of Biomedical and Biotechnological Sciences, University of Catania, Catania - Italy.; Centre for Research and Consultancy in HTA and Drug Regulatory Affairs (CERD), University of Catania, Catania - Italy. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%229918417986506676%22">Global & regional health technology assessment</searchLink> [Glob Reg Health Technol Assess] 2026 Feb 09; Vol. 13, pp. 24-32. <i>Date of Electronic Publication: </i>2026 Feb 09 (<i>Print Publication: </i>2026). – Name: TypePub Label: Publication Type Group: TypPub Data: Journal Article – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22AboutScience%22">AboutScience </searchLink><i>Country of Publication: </i>Italy <i>NLM ID: </i>9918417986506676 <i>Publication Model: </i>eCollection <i>Cited Medium: </i>Internet <i>ISSN: </i>2283-5733 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2222842403%22">22842403 </searchLink><i>NLM ISO Abbreviation: </i>Glob Reg Health Technol Assess <i>Subsets: </i>PubMed not MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=41669617 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.33393/grhta.2026.3675 Languages: – Code: ita Text: Italian PhysicalDescription: Pagination: StartPage: 24 Titles: – TitleFull: La cooperazione tra gli stakeholder per la sostenibilità del nuovo paradigma farmaceutico in Italia. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Drago V – PersonEntity: Name: NameFull: Di Brino E – PersonEntity: Name: NameFull: Laurita R – PersonEntity: Name: NameFull: Rumi F – PersonEntity: Name: NameFull: Basile M – PersonEntity: Name: NameFull: Pierini A – PersonEntity: Name: NameFull: Ponzianelli A – PersonEntity: Name: NameFull: Patarnello F – PersonEntity: Name: NameFull: Ianna P – PersonEntity: Name: NameFull: Drago F IsPartOfRelationships: – BibEntity: Dates: – D: 09 M: 02 Text: 2026 Feb 09 Type: published Y: 2026 Identifiers: – Type: issn-electronic Value: 2283-5733 Numbering: – Type: volume Value: 13 Titles: – TitleFull: Global & regional health technology assessment Type: main |
| ResultId | 1 |